Genecode Ltd is an R&D company focussing on the discovery and development of innovative preclinical drug candidates and the commercialization of novel technologies mostly in the field of biomedicine and gene technology.
Genecode AS, formerly Balti Tehnoloogiaarenduse AS, was found in 1993. GeneCode is an R&D company focussing on commercialization of novel technologies mostly in the field of biomedicine and gene technology. The research is concentrated on the discovery and development of innovative preclinical drug candidates.
GeneCode has 4 daughter and affiliated companies: OliCode AS, NeuronCode AS, CERE Code AS and BTD Medic OÜ.
Our company is managed by the Executive Team and supervised by the Board of Non-Executive Directors.
The role of GeneCode Supervisory Board is to oversee and advise the Board of Directors and Executive Team. The Supervisory Board is directly involved in decisions on matters of fundamental importance to the company. It also holds regular discussions with the Executive Team on the company’s business strategy and status of its implementation.
The members of the Supervisory Board are:
The Executive Director has the authority to run the organization. The Executive Director is accountable to the Chairman of the Supervisory Board and reports to the Board on a regular basis. The Managing Director is responsible for the management of the day-to-day business and has full right to act and represent the Company in everyday business.
The members of the Executive Team are:
Scientific Team Leaders supervise research groups. They are wellknown professors in the strategic field of interest. GeneCode has three scientific teams:
Our long-term R&D partners are: